Portable, patented hematology analyzer

What Makes our Technology Different:

  • Broadest applicability (usable for any species with red blood cells)VioCyte hematology platform
  • Simplicity (1 step, 1 reagent, zero lysing)
  • Portable (battery-operated for true field use)
  • Small footprint (tabletop size)
  • Rapid results (<5 minutes)

 

Measurement Principle

 

US Patent 11579139:

Differentiation of Blood Cell Types by Hemoglobin Content

  • Red Blood Cells absorb 405 nm laser light very strongly due to their Hemoglobin content.
  • White Blood Cells and Platelets do not absorb light at this wavelength.
  • By measuring absorbance and light scatter, Red Blood Cells, White Blood Cells, and Platelets are distinguished and counted in a single step by flow cytometry.
  • All cells in a μL sample are counted. The sample is collected by lancet finger stick or from another tube into a μL tube by capillary action.
  • Blood collection does not require a phlebotomist.
    • It can be self-administered, as in glucose monitoring.
  • The full 22-parameter Complete Blood Count and 5-part White Blood Cell Differential is obtained, including Red Blood Cell indices.
  • Red Blood Cells are sphered by reagent surfactant in order to obtain Hemoglobin and other Red Blood Cell indices.
  • A single, inexpensive, and long-term stable reagent serves as diluent, sheath, and rinse.

 

 

What We Are Delivering

VioCyte is bringing to market a next-generation hematology platform capable of producing a complete blood count with white blood cell differential on any human or animal species with hemoglobin.

Unlike conventional analyzers, the VioCyte platform:VioCyte hematology platform chip

  • Operates without multi-reagent chemistries
  • Eliminates many common analytical interferences
  • Supports true multi-species testing by design
  • Enables point-of-care and decentralized use

See a sampling of our test results below: